Table 1.
Open in new tab

Based on a simulation covering a total of 180 months, impact of various dialysis strategies on the monthly per-patient costs and on the initial distribution at RRT start, the total time spent in each modality, the number of transitions and the mean lifetime for patients aged 18–44 years without diabetes

Cohort = 823 incident patientsStatus quoRenal TR, all donorsRenal TR, deceased donorRenal TR, living donorCombined: CAPD, APD and home HDNon-assisted CAPD, transfer to self-care unitNon-assisted CAPD, transfer to home HDNon-assisted APDNon-assisted APD, transfer to home HDNon-assisted CAPDNon-assisted APD, transfer to self-care unitHome HDDaily home HD
Cost/months (euros) for 1 patient2684221622332443258426182618261926232625262426562714
Comparison with status quo (euros/months)−468−451−240−100−66−65−64−61−59−60−2730
Initial distribution at RRT start (%)
 Hospital-based HD61.761.761.761.742.446.146.146.446.446.146.461.761.7
 Assisted automated PD1.51.51.51.51.51.51.51.51.51.51.51.51.5
 Non-assisted automated PD7.77.77.77.719.27.77.723.023.07.723.07.77.7
 Assisted continuous PD1.21.21.21.21.21.21.21.21.21.21.21.21.2
 Non-assisted continuous PD5.25.25.25.213.120.920.95.25.220.95.25.25.2
 HD self-care unit8.78.78.78.78.78.78.78.78.78.78.78.78.7
 HD home0.30.30.30.30.30.30.30.30.30.30.30.30.3
 Facility under medical supervision2.52.52.52.52.52.52.52.52.52.52.52.52.5
 Renal graft deceased donor8.58.58.58.58.58.58.58.58.58.58.58.58.5
 Renal graft living donor2.72.72.72.72.72.72.72.72.72.72.72.72.7
Distribution of the total time spent in each modality (%)
 Hospital-based HD11.37.67.79.59.010.09.910.19.910.29.910.610.6
 Assisted automated PD0.20.10.20.20.20.20.20.20.20.20.20.20.2
 Non-assisted automated PD1.50.90.91.22.31.91.93.22.72.02.51.51.5
 Assisted continuous PD0.20.10.10.20.20.20.20.20.20.20.20.20.2
 Non-assisted continuous PD0.80.50.60.71.21.81.90.80.82.40.80.80.8
 HD self-care unit12.86.26.49.412.412.211.411.411.311.512.712.212.2
 HD home0.70.30.30.51.40.61.40.61.70.60.61.71.7
 Facility under medical supervision2.71.41.42.12.32.52.52.52.42.52.42.62.6
 Renal graft deceased donor61.371.573.260.962.161.861.862.161.961.661.861.661.6
 Renal graft living donor8.611.49.315.69.09.08.98.98.98.98.98.78.7
Number of transitions entering each modality (per 823 patients)
 Hospital-based HD788742743764644676675683674684676787787
 Assisted automated PD19181818212020202020201919
 Non-assisted automated PD111104104107218143144235234149234110110
 Assisted continuous PD15141415151616151516151515
 Non-assisted continuous PD636161621271911926564192636363
 HD self-care unit514435439473507490459462460462512502502
 HD home29222226632654266627267979
 Facility under medical supervision146113114129127135134134132135133141141
 Renal graft deceased donor720824842714732725726728729721727724724
 Renal graft living donor8210888150868584858484848282
Number of deaths (per 823 patients)156120122135146151151150149154149153153
Restricted mean lifetime (months)161.9166.2165.9164.3163.6162.7162.7163163.1162.3163162.3162.3
Cohort = 823 incident patientsStatus quoRenal TR, all donorsRenal TR, deceased donorRenal TR, living donorCombined: CAPD, APD and home HDNon-assisted CAPD, transfer to self-care unitNon-assisted CAPD, transfer to home HDNon-assisted APDNon-assisted APD, transfer to home HDNon-assisted CAPDNon-assisted APD, transfer to self-care unitHome HDDaily home HD
Cost/months (euros) for 1 patient2684221622332443258426182618261926232625262426562714
Comparison with status quo (euros/months)−468−451−240−100−66−65−64−61−59−60−2730
Initial distribution at RRT start (%)
 Hospital-based HD61.761.761.761.742.446.146.146.446.446.146.461.761.7
 Assisted automated PD1.51.51.51.51.51.51.51.51.51.51.51.51.5
 Non-assisted automated PD7.77.77.77.719.27.77.723.023.07.723.07.77.7
 Assisted continuous PD1.21.21.21.21.21.21.21.21.21.21.21.21.2
 Non-assisted continuous PD5.25.25.25.213.120.920.95.25.220.95.25.25.2
 HD self-care unit8.78.78.78.78.78.78.78.78.78.78.78.78.7
 HD home0.30.30.30.30.30.30.30.30.30.30.30.30.3
 Facility under medical supervision2.52.52.52.52.52.52.52.52.52.52.52.52.5
 Renal graft deceased donor8.58.58.58.58.58.58.58.58.58.58.58.58.5
 Renal graft living donor2.72.72.72.72.72.72.72.72.72.72.72.72.7
Distribution of the total time spent in each modality (%)
 Hospital-based HD11.37.67.79.59.010.09.910.19.910.29.910.610.6
 Assisted automated PD0.20.10.20.20.20.20.20.20.20.20.20.20.2
 Non-assisted automated PD1.50.90.91.22.31.91.93.22.72.02.51.51.5
 Assisted continuous PD0.20.10.10.20.20.20.20.20.20.20.20.20.2
 Non-assisted continuous PD0.80.50.60.71.21.81.90.80.82.40.80.80.8
 HD self-care unit12.86.26.49.412.412.211.411.411.311.512.712.212.2
 HD home0.70.30.30.51.40.61.40.61.70.60.61.71.7
 Facility under medical supervision2.71.41.42.12.32.52.52.52.42.52.42.62.6
 Renal graft deceased donor61.371.573.260.962.161.861.862.161.961.661.861.661.6
 Renal graft living donor8.611.49.315.69.09.08.98.98.98.98.98.78.7
Number of transitions entering each modality (per 823 patients)
 Hospital-based HD788742743764644676675683674684676787787
 Assisted automated PD19181818212020202020201919
 Non-assisted automated PD111104104107218143144235234149234110110
 Assisted continuous PD15141415151616151516151515
 Non-assisted continuous PD636161621271911926564192636363
 HD self-care unit514435439473507490459462460462512502502
 HD home29222226632654266627267979
 Facility under medical supervision146113114129127135134134132135133141141
 Renal graft deceased donor720824842714732725726728729721727724724
 Renal graft living donor8210888150868584858484848282
Number of deaths (per 823 patients)156120122135146151151150149154149153153
Restricted mean lifetime (months)161.9166.2165.9164.3163.6162.7162.7163163.1162.3163162.3162.3

Shaded values correspond to the modalities of treatment impacted by the given strategy. Bold values correspond to hospital-based HD.

Table 1.
Open in new tab

Based on a simulation covering a total of 180 months, impact of various dialysis strategies on the monthly per-patient costs and on the initial distribution at RRT start, the total time spent in each modality, the number of transitions and the mean lifetime for patients aged 18–44 years without diabetes

Cohort = 823 incident patientsStatus quoRenal TR, all donorsRenal TR, deceased donorRenal TR, living donorCombined: CAPD, APD and home HDNon-assisted CAPD, transfer to self-care unitNon-assisted CAPD, transfer to home HDNon-assisted APDNon-assisted APD, transfer to home HDNon-assisted CAPDNon-assisted APD, transfer to self-care unitHome HDDaily home HD
Cost/months (euros) for 1 patient2684221622332443258426182618261926232625262426562714
Comparison with status quo (euros/months)−468−451−240−100−66−65−64−61−59−60−2730
Initial distribution at RRT start (%)
 Hospital-based HD61.761.761.761.742.446.146.146.446.446.146.461.761.7
 Assisted automated PD1.51.51.51.51.51.51.51.51.51.51.51.51.5
 Non-assisted automated PD7.77.77.77.719.27.77.723.023.07.723.07.77.7
 Assisted continuous PD1.21.21.21.21.21.21.21.21.21.21.21.21.2
 Non-assisted continuous PD5.25.25.25.213.120.920.95.25.220.95.25.25.2
 HD self-care unit8.78.78.78.78.78.78.78.78.78.78.78.78.7
 HD home0.30.30.30.30.30.30.30.30.30.30.30.30.3
 Facility under medical supervision2.52.52.52.52.52.52.52.52.52.52.52.52.5
 Renal graft deceased donor8.58.58.58.58.58.58.58.58.58.58.58.58.5
 Renal graft living donor2.72.72.72.72.72.72.72.72.72.72.72.72.7
Distribution of the total time spent in each modality (%)
 Hospital-based HD11.37.67.79.59.010.09.910.19.910.29.910.610.6
 Assisted automated PD0.20.10.20.20.20.20.20.20.20.20.20.20.2
 Non-assisted automated PD1.50.90.91.22.31.91.93.22.72.02.51.51.5
 Assisted continuous PD0.20.10.10.20.20.20.20.20.20.20.20.20.2
 Non-assisted continuous PD0.80.50.60.71.21.81.90.80.82.40.80.80.8
 HD self-care unit12.86.26.49.412.412.211.411.411.311.512.712.212.2
 HD home0.70.30.30.51.40.61.40.61.70.60.61.71.7
 Facility under medical supervision2.71.41.42.12.32.52.52.52.42.52.42.62.6
 Renal graft deceased donor61.371.573.260.962.161.861.862.161.961.661.861.661.6
 Renal graft living donor8.611.49.315.69.09.08.98.98.98.98.98.78.7
Number of transitions entering each modality (per 823 patients)
 Hospital-based HD788742743764644676675683674684676787787
 Assisted automated PD19181818212020202020201919
 Non-assisted automated PD111104104107218143144235234149234110110
 Assisted continuous PD15141415151616151516151515
 Non-assisted continuous PD636161621271911926564192636363
 HD self-care unit514435439473507490459462460462512502502
 HD home29222226632654266627267979
 Facility under medical supervision146113114129127135134134132135133141141
 Renal graft deceased donor720824842714732725726728729721727724724
 Renal graft living donor8210888150868584858484848282
Number of deaths (per 823 patients)156120122135146151151150149154149153153
Restricted mean lifetime (months)161.9166.2165.9164.3163.6162.7162.7163163.1162.3163162.3162.3
Cohort = 823 incident patientsStatus quoRenal TR, all donorsRenal TR, deceased donorRenal TR, living donorCombined: CAPD, APD and home HDNon-assisted CAPD, transfer to self-care unitNon-assisted CAPD, transfer to home HDNon-assisted APDNon-assisted APD, transfer to home HDNon-assisted CAPDNon-assisted APD, transfer to self-care unitHome HDDaily home HD
Cost/months (euros) for 1 patient2684221622332443258426182618261926232625262426562714
Comparison with status quo (euros/months)−468−451−240−100−66−65−64−61−59−60−2730
Initial distribution at RRT start (%)
 Hospital-based HD61.761.761.761.742.446.146.146.446.446.146.461.761.7
 Assisted automated PD1.51.51.51.51.51.51.51.51.51.51.51.51.5
 Non-assisted automated PD7.77.77.77.719.27.77.723.023.07.723.07.77.7
 Assisted continuous PD1.21.21.21.21.21.21.21.21.21.21.21.21.2
 Non-assisted continuous PD5.25.25.25.213.120.920.95.25.220.95.25.25.2
 HD self-care unit8.78.78.78.78.78.78.78.78.78.78.78.78.7
 HD home0.30.30.30.30.30.30.30.30.30.30.30.30.3
 Facility under medical supervision2.52.52.52.52.52.52.52.52.52.52.52.52.5
 Renal graft deceased donor8.58.58.58.58.58.58.58.58.58.58.58.58.5
 Renal graft living donor2.72.72.72.72.72.72.72.72.72.72.72.72.7
Distribution of the total time spent in each modality (%)
 Hospital-based HD11.37.67.79.59.010.09.910.19.910.29.910.610.6
 Assisted automated PD0.20.10.20.20.20.20.20.20.20.20.20.20.2
 Non-assisted automated PD1.50.90.91.22.31.91.93.22.72.02.51.51.5
 Assisted continuous PD0.20.10.10.20.20.20.20.20.20.20.20.20.2
 Non-assisted continuous PD0.80.50.60.71.21.81.90.80.82.40.80.80.8
 HD self-care unit12.86.26.49.412.412.211.411.411.311.512.712.212.2
 HD home0.70.30.30.51.40.61.40.61.70.60.61.71.7
 Facility under medical supervision2.71.41.42.12.32.52.52.52.42.52.42.62.6
 Renal graft deceased donor61.371.573.260.962.161.861.862.161.961.661.861.661.6
 Renal graft living donor8.611.49.315.69.09.08.98.98.98.98.98.78.7
Number of transitions entering each modality (per 823 patients)
 Hospital-based HD788742743764644676675683674684676787787
 Assisted automated PD19181818212020202020201919
 Non-assisted automated PD111104104107218143144235234149234110110
 Assisted continuous PD15141415151616151516151515
 Non-assisted continuous PD636161621271911926564192636363
 HD self-care unit514435439473507490459462460462512502502
 HD home29222226632654266627267979
 Facility under medical supervision146113114129127135134134132135133141141
 Renal graft deceased donor720824842714732725726728729721727724724
 Renal graft living donor8210888150868584858484848282
Number of deaths (per 823 patients)156120122135146151151150149154149153153
Restricted mean lifetime (months)161.9166.2165.9164.3163.6162.7162.7163163.1162.3163162.3162.3

Shaded values correspond to the modalities of treatment impacted by the given strategy. Bold values correspond to hospital-based HD.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close